Evolus, Inc.EOLS

$6.63-0.11 (-1.63%)

NASDAQHealthcare24:00 UTC

Company snapshot

Market Cap

$432M

Small-cap

+99%

2018 — today

10-Year Price

-43%

2018 — today

52-Week Range

$3.94$9.73

Current $6.63· 46%

Evolus, Inc. is a performance beauty enterprise that furnishes the United States market with medical aesthetic solutions for healthcare professionals and their patients. A key product in its portfolio is Jeuveau, a proprietary 900 kilodalton purified botulinum toxin type A formulation. This product is specifically designed for adults seeking the temporary smoothing of moderate to severe glabellar (frown) lines. Founded in 2012, Evolus, Inc. maintains its corporate headquarters in Newport Beach, California.

Valuation in context

P/E ratio

-9.9

N/A

Not meaningful — company is unprofitable

P/B ratio

-15.0

N/A

Not meaningful — company is unprofitable

FCF Yield

-9.6%

Around average

Around the 10-year average

Free · No credit card needed

Get alerted when EOLS is cheap

Set a free alert — we'll push you when P/E, yield, or other metrics cross a historical threshold.